Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 4, 2010, Pages

  Katchamart, Wanruchada ^a   Trudeau, Judith ^b   Phumethum, Veerapong ^c   Bombardier, Claire ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Hotel Dieu de Levis Hospital   (Canada)

^c PRAPOKKLAO HOSPITAL   (Thailand)

^d INSTITUTE FOR WORK AND HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; BUCILLAMINE; CHLOROQUINE; CYCLOSPORINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOXYCYCLINE; GOLD DERIVATIVE; HYDROXYCHLOROQUINE; LEFLUNOMIDE; LEVOFLOXACIN; METHOTREXATE; PENICILLAMINE; PLACEBO; SALAZOSULFAPYRIDINE; ZOLEDRONIC ACID; ANTIRHEUMATIC AGENT;

BLOOD TOXICITY; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; GENERAL CONDITION IMPROVEMENT; HUMAN; INFECTION; JOINT SWELLING; LIVER TOXICITY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; TREATMENT DURATION; ADULT; DRUG COMBINATION; META ANALYSIS; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; HUMANS; METHOTREXATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77952467678     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008495     Document Type: Review

References (56)

1. Capell HA, Madhok R, Porter DR, et al. Combiantion therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with suboptimal response to sulfasalazine:results from double-blind placebo-controlled MASCOT study. Ann Rheum Dis 2007;66:235-41.
2. Dougados M, Combe B, Cantagrel A, et al. Combination therapy in early rheumatoid arthritis:a randomised, controlled, double blind 52 week clinical trial of sulfasalazine and methotrexate compared with single components. Ann Rheum Dis 1999;58:220-5.
3. Ferraz MB, Pinheiro GR, Helfenstein M, et al. Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A multicenter randomized placebo-controlled trial. Scand J Rheum 1994;23(5):231-6.
4. Haagsma CJ, Van RielP, De Rooij D, et al. Combination of methotrexate and sulphasalazine vs methotrexate alone: A randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy. Br J Rheumatol 1994;33(11):1049-51.
5. Haagsma CJ, van Riel PL, de Jong A.J, et al. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol 1997;36(10):1082-8.
6. Hanyu T, Arai K, Ichikawa H, et al. Long-term methotrexate (MTX) combination therapy versus MTX alone for active rheumatoid arthritis. Japanease J Rheumatol 1999;9(1):31-44.
7. Hetland ML, Stengaard-Pedersen K, Junker P, et al. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum 2006;54(5):1401-9.
8. Ichikawa Y, Saito T, Yamanaka H et al. Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: A multicenter, double-blind, randomized controlled study. Mod Rheumatol 2005;15:323-8.
9. Islam MN, Alam MN, Haq SA, et al. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis. Bangladesh Med Res Counc Bull 2000;25(1):1-7.
10. Jarrett SJ, Conaghan PG, Sloan VS, et al. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum 2006;54(5):1410-4.
11. Kremer JM, Genovese MC, Cannon GW, et al. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: A randomized, double-blind, placebo-controlled trial. Ann Int Med 2002;137:726-33.
12. Lehman AJ, Esdaile JM, KinkhoffAV, et al. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: Results of the METGO study. Arthritis Rheum 2005;52(5):1360-70.
13. Marchesoni A, Battafarano N, Arreghini M, et al. Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone. Rheumatology 2003;42:1545-9.
14. O'Dell JR, Haire C, Erikson N, et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334(20):1287-91.
15. O'Dell JR, Elliott JR, Mallek JA, et al. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. Arthritis Rheum 2006;54(2):621-7.
16. Ogrendik M. Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate. Southern Med J 2007;100(2):135-9.
17. Tascioglu F, Oner C, Armagan O. Comparison of low dose methotrexate and combination therapy with methotrexate and sulphasalazine in the treatment of early rheumatoid arthritis. J Rheum Med Rehab 2003;14(3):142-9.
18. Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med 1995;333(3):137-41.
19. Williams HJ, Ward JR, Reading J, et al. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1992;35(8):849-56.
20. Willkens RF, Sharp JT, Stablein D, et al. Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment. Arthritis Rheum 1995;38(12):1799-806.
21. Calguneri M, Pay S, Calikaner Z. Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis. Clin Exp Rheum 1999;17:699-704.
22. Clegg DO, Frederick D, Duffy J, et al. Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine. J Rheum 1997;24(10):1896-902.
23. Haagsma CJ, Van Riel PLCM, Van de Putte LBA. Combination sulfasalazine and methotrexate in rheumatoid arthritis:early clinical impressions. Br J Rheum 1995;34(suppl 2):104-8.
24. Kremer J, Genovese M, Cannon GW. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomised, double-blind, placebo controlled trial. J Rheum 2004;31:1521-31.
25. Maillefert JF, Combe B, Goupille P. Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind controlled study. Ann Rheum Dis 2003;62:764-6.
26. Matucci-Cerinic M. Leflunomide improves the clinical response in patients iwth active rheumatoid arthritis treated with methotrexate. Clin Exp Rheum 2003;21(6):695-6.
27. Mottaghi P, Karimzade H. Does chloroquine decrease liver enzyme abnormalities induced by methotrexate in patients with rheumatoid arthritis?. J Res Med Science 2005;10(3):135-8.
28. Mroczkowski PJ, Weinblatt ME, Kremer JM. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis. Clin Exp Rheum 1999;17(suppl18):S66-8.
29. Nagashima M, Matsuoka T, Saitoh K. Treatment continuation rate in relation to efficacy and toxicity in long-term therapy with low-dose methotrexate, sulfasalazine, and bucillamine in 1, 358 Japanese patients with rheumatoid arthritis. Clin Exp Rheum 2006;24:260-7.
30. Nisar M, Carlisle L, Amos RS. Methotrexate and sulfasalazine as combination therapy in rheumatoid arthritis. Br J Rheum 1994;33:651-4.
31. O'Dell JR, Haire C, Erison N, et al. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate. J Rheum 1996;23(suppl44):72-4.
32. Rau R, Schleusser B, Herborn G. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy. J Rheum 1998;25(8):1485-92.
33. Stein MC, Pincus T, Yocum D. Combination treatment of severe rheumatoid arthritis with cyclosporin and methotrexate for forty-eight weeks: an open-label extension study. Arthritis Rheum 1997;40(10):1843-51.
34. Trnavsky K, Batterova J, Linduskova M, et al. Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis. Z Rheum 1993;52:292-6.
35. Willkens RF, Stablein D. Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: a 48 week controlled clinical trial. J Rheum 1996;44(suppl):64-8.
36. Bukhari M, Wiles M, Lunt M, et al. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception study [Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception study]. Arthritis Rheum 2003;48(1):46-53.
37. Bykerk V, Keystone E. What are the goals and principles of management in the early treatment of rheumatoid arthritis? [What are the goals and principles of management in the early treatment of rheumatoid arthritis?]. Best Pract Res Clin Rheumatol 2005;19(1):147-61.
38. Choy EHS, Smith C, Dore CJ, Scott DL. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology 2005;44(11):1414-21.
39. Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, et al. Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis. Ann Intern Med 2008;148(2):124-34.
40. Felson D, Anderson JJ, Boers M, Bombardier C, et al. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials [The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials]. Arthritis Rheum 1993;36(6):729-40.
41. Felson DT, Anderson JJ, Meenan RF. The efficacy and toxicity of combination therapy in rheumatoid arthritis: A meta-analysis. Arthritis Rheum 1994;37(10):1487-91.
42. Felson D, Anderson J, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American college of rheumatology preliminary definition of improvement in rheumatoid arthritis [American college of rheumatology preliminary definition of improvement in rheumatoid arthritis]. Arthritis Rheum 1995;38(6):727-35.
43. Goekoop-Ruiterman YPM, de Vries-Bouwstra J, Allaart C, van Zeben D, Kerstens PJSM, Hazes J, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomised, controlled trial. Arthritis Rheum 2005;52(11):3381-90.
44. Goekoop-Ruiterman YPM, de Vries-Bouwstra J, Allaart C, van Zeben D, Kerstens PJSM, Hazes J, et al. Comparison of treatment strategies in early rheumatoid arthritis: A randomised Trial. Ann Intern Med 2007;146(6):406-15.
45. Heath CJ, Fortin P. Epidemiologic studies of rheumatoid arthritis: future directions [Epidemiologic studies of rheumatoid arthritis: future directions]. J Rheum 1992;32(Suppl):74-7.
46. Hochberg MC, Tracy JK, Flores RH. 'Stepping-up' from methotrexate: A systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate. Ann Rheum Dis 2001;60(SUPPL. 3):iii51-iii4.
47. Makinen H, Kautiainen H, Hannonen P, et al. Sustained Remission and Reduced Radiographic Progression with Combination Disease Modifying Antirheumatic Drugs in Early Rheumatoid Arthritis [Sustained Remission and Reduced Radiographic Progression with Combination Disease Modifying Antirheumatic Drugs in Early Rheumatoid Arthritis]. J Rheumatology 2007;34(2):316-21.
48. Möttönen T, Hannonen P, Leirisalo-RepoM, Nissilä M, Kautiainen H, Korpela M. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 1999;353(9164):1568-73.
49. OMERACT. Outcome measures in rheumatoid arthritis clinical trials. J Rheumatol 1993 1993;20(3):526-91.
50. Pinals R, Alfonse T, Larsen R. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24(10):1308-15.
51. Prevoo MLL, Van't Hof MA, Kuper HH, Van Leeuwen MA, Van de Putte LB, Van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38(1):44-8.
52. van der Heijde DM, van't Hof MA, van Riel PL, van Leeuwen MA, van Rijswijk MH, van de Putte LB. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 1992;51(2):177-81.
53. van der Heijde A, Jacobs JWG, Bijlsma JWJ. The Effectiveness of Early Treatment with "Second-Line" Antirheumatic Drugs: A Randomized, Controlled Trial. Ann Intern Med 1996;124(8):699-707.
54. Van Gestel AM, Prevoo MLL, Van't Hof MA, Van Rijswijk MH, Van de Putte LBA, Van Riel PLCM. Development and validation of the European league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary American College of Rheumatology and the world health organization/international league against rheumatism criteria. ArthritisRheum 1996;39(1):34-40.
55. Verhoeven AC, Boers M, Tugwell P. Combination therapy in rheumatoid arthritis: updated systematic review. Br Rheumatol 1998;37(6):612-9.
56. Katchamart W, Trudeau J, Phumethum V, Bombardier C. The efficacy and toxicity of methotrexate (MTX) monotherapy vs. MTX combination therapy with non-biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis: A systematic review and meta-analysis. Ann Rheum Dis 2009;68(7):1105-12.